Scudiero Fernando, Pitì Antonino, Keim Roberto, Parodi Guido
Cardiology Unit, Medical Sciences Departement, ASST Bergamo Est, Via Paderno 21, 24068 Seriate, Italy.
Intensive Care Unit, Medical Sciences Departement, ASST Bergamo Est, Via Paderno 21, 24068 Seriate, Italy.
Eur Heart J Case Rep. 2020 Dec 28;5(1):ytaa388. doi: 10.1093/ehjcr/ytaa388. eCollection 2021 Jan.
Despite the fast-growing understanding of the coronavirus disease 2019 (COVID-19), patient management remains largely empirical or based on retrospective studies. In this complex scenario, an important clinical issue appears to be represented by the high prevalence of thromboembolic events, but the data regarding high-risk pulmonary embolism (PE) is still not available.
A patient with COVID-19 developed sudden shortness of breath and hypoxia. Early echocardiographic diagnosis of high-risk PE related to right heart thrombus was performed. Systemic thrombolysis was administered with excellent clinical and haemodynamic response.
Pulmonary thromboembolism is a common occurrence in severe COVID-19 infection. In our experience, systemic thrombolysis proved to be effective and for this reason may be considered for life-threatening PE in COVID-19 patients.
尽管对2019冠状病毒病（COVID-19）的认识迅速增加，但患者管理在很大程度上仍基于经验或回顾性研究。在这种复杂情况下，血栓栓塞事件的高发生率似乎是一个重要的临床问题，但关于高危肺栓塞（PE）的数据仍然缺乏。
一名COVID-19患者突然出现呼吸急促和缺氧。早期经超声心动图诊断为与右心血栓相关的高危PE。给予全身溶栓治疗，临床和血流动力学反应良好。
肺血栓栓塞在严重COVID-19感染中很常见。根据我们的经验，全身溶栓被证明是有效的，因此对于COVID-19患者的危及生命的PE可考虑使用。
